Department of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Department of Physiology & Biophysics, School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
Angiogenesis. 2019 May;22(2):295-309. doi: 10.1007/s10456-018-9657-y. Epub 2019 Jan 3.
Angiogenesis is a multistep process that requires highly regulated endothelial cell (EC) behavior. The transcription factor Krüppel-like factor 4 (KLF4) is a critical regulator of several basic EC functions; we have recently shown that KLF4 disturbs pathological (tumor) angiogenesis by mediating the expression of members of VEGF and Notch signaling pathways. Notch signaling is central to orchestration of sprouting angiogenesis but little is known about the upstream regulation of Notch itself. To determine the role of KLF4 in normal (developmental) angiogenesis, we used a mouse retinal angiogenesis model. We found that endothelial-specific overexpression of KLF4 in transgenic mice (EC-K4 Tg) leads to increased vessel density, branching and number of tip cell filopodia as assessed on postnatal day 6 (P6). The hypertrophic vasculature seen with sustained KLF4 overexpression is not stable and undergoes prominent remodeling during P7-P12 resulting in a normal appearing retinal vasculature in adult EC-K4 Tg mice. We find that KLF4 inhibits Delta-like 4 (DLL4) expression in the angiogenic front during retinal vascular development. Furthermore, in an oxygen-induced retinopathy model, overexpression of KLF4 results in decreased vaso-obliteration and neovascular tuft formation that is similar to genetic or pharmacologic DLL4 inhibition. Mechanistically, we show that KLF4 disables the activity of the essential Notch transcriptional activator RBP-J by interfering with binding of co-activators NICD and MAML at intron 3 of the Notch ligand DLL4. In summary, our experimental results demonstrate a regulatory role of KLF4 in developmental angiogenesis through regulation of DLL4 transcription.
血管生成是一个多步骤的过程,需要高度调节的内皮细胞(EC)行为。转录因子 Krüppel 样因子 4(KLF4)是几个基本 EC 功能的关键调节剂;我们最近表明,KLF4 通过介导 VEGF 和 Notch 信号通路成员的表达来干扰病理性(肿瘤)血管生成。Notch 信号通路是协调发芽血管生成的核心,但 Notch 本身的上游调节知之甚少。为了确定 KLF4 在正常(发育)血管生成中的作用,我们使用了小鼠视网膜血管生成模型。我们发现,内皮细胞特异性过表达 KLF4 的转基因小鼠(EC-K4 Tg)导致血管密度增加、分支增加和尖端细胞丝状伪足数量增加,这在出生后第 6 天(P6)进行评估。在持续过表达 KLF4 时看到的肥大血管不稳定,并在 P7-P12 期间经历明显的重塑,导致成年 EC-K4 Tg 小鼠的视网膜血管正常出现。我们发现 KLF4 在视网膜血管发育过程中抑制血管生成前沿的 Delta-like 4(DLL4)表达。此外,在氧诱导的视网膜病变模型中,过表达 KLF4 导致血管闭塞减少和新生血管簇形成,这类似于基因或药物 DLL4 抑制。从机制上讲,我们表明 KLF4 通过干扰 Notch 配体 DLL4 内含子 3 上的共激活子 NICD 和 MAML 的结合来使 Notch 转录激活剂 RBP-J 的活性失活。总之,我们的实验结果表明,KLF4 通过调节 DLL4 转录在发育性血管生成中发挥调节作用。